Superiority of 18F-NaF PET/CT for the detection of bone metastases. - Suppr | 超能文献

Superiority of 18F-NaF PET/CT for the detection of bone metastases.

作者信息

Lapa Paula, Pedroso de Lima João

机构信息

Department of Nuclear Medicine, Coimbra Hospital and University Center.

Institute of Nuclear Sciences Applied to Health-ICNAS, University of Coimbra, Coimbra, Portugal.

出版信息

Nucl Med Commun. 2018 Apr;39(4):344-345. doi: 10.1097/MNM.0000000000000806.

DOI:10.1097/MNM.0000000000000806

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Superiority of 18F-NaF PET/CT for the detection of bone metastases.

Nucl Med Commun. 2018 Apr;39(4):344-345. doi: 10.1097/MNM.0000000000000806.

2

[Superiority of 18F-FNa PET/CT for Detecting Bone Metastases in Comparison with Other Diagnostic Imaging Modalities].[18F-FNa PET/CT在检测骨转移方面相对于其他诊断成像方式的优越性]

Acta Med Port. 2017 Jan 31;30(1):53-60. doi: 10.20344/amp.7818.

3

18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.与18F-NaF PET/CT相比，18F-FDG PET/CT是乳腺癌骨转移患者的一种预后生物标志物。

Nuklearmedizin. 2015;54(4):163-72. doi: 10.3413/Nukmed-0727-15-02. Epub 2015 Jul 13.

4

Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.对平面骨闪烁显像、单光子发射计算机断层扫描（SPECT）、SPECT/CT、18F-氟化钠正电子发射断层显像/计算机断层扫描（PET/CT）以及全身1.5T磁共振成像（MRI，包括扩散加权成像（DWI））用于检测高危乳腺癌和前列腺癌患者骨转移的前瞻性评估：SKELETA临床试验。

Acta Oncol. 2016;55(1):59-67. doi: 10.3109/0284186X.2015.1027411. Epub 2015 Apr 2.

5

18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer.18F-氟化物PET/CT肿瘤负荷定量可预测乳腺癌患者的生存情况。

Oncotarget. 2017 May 30;8(22):36001-36011. doi: 10.18632/oncotarget.16418.

6

Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.前瞻性评估 99mTc-MDP 闪烁扫描、18F-NaF PET/CT、18F-FDG PET/CT 和全身 MRI 检测骨骼转移的初步研究。

Clin Nucl Med. 2013 Jul;38(7):e290-6. doi: 10.1097/RLU.0b013e3182815f64.

7

Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer.鸡尾酒 18F-FDG 和 18F-NaF PET/CT 对乳腺癌骨转移的单独 18F-FDG PET/CT 检测的增量价值。

Clin Nucl Med. 2017 May;42(5):335-340. doi: 10.1097/RLU.0000000000001615.

8

Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?PET/CT时代乳腺癌患者骨转移的检测：我们仍然需要骨扫描吗？

Rev Esp Med Nucl Imagen Mol. 2016 Jan-Feb;35(1):3-11. doi: 10.1016/j.remn.2015.08.006. Epub 2015 Oct 26.

9

18F-NaF PET/CT Imaging of Brain Metastases.18F-NaF PET/CT 脑转移瘤成像。

Clin Nucl Med. 2016 Jul;41(7):564-5. doi: 10.1097/RLU.0000000000001186.

10

Utility of 18F-fluorodeoxy glucose and 18F-sodium fluoride positron emission tomography/computed tomography in the diagnosis of medication-related osteonecrosis of the jaw: A preclinical study in a rat model.18F-氟脱氧葡萄糖和18F-氟化钠正电子发射断层扫描/计算机断层扫描在诊断药物相关性颌骨坏死中的应用：大鼠模型的临床前研究

J Craniomaxillofac Surg. 2016 Apr;44(4):357-63. doi: 10.1016/j.jcms.2016.01.009. Epub 2016 Jan 14.

引用本文的文献

1

Preoperative Assessment of Medication-Related Osteonecrosis of the Jaw Using [18F]fluoride Positron Emission Tomography (PET)/CT and [18F]fluorodeoxyglucose PET/MRI in Correlation with Histomorphometry and Micro-CT-A Prospective Comparative Study.使用[18F]氟化物正电子发射断层扫描（PET）/CT和[18F]氟脱氧葡萄糖PET/MRI对颌骨药物相关性骨坏死进行术前评估，并与组织形态计量学和显微CT进行相关性分析：一项前瞻性比较研究

Diagnostics (Basel). 2024 Feb 15;14(4):428. doi: 10.3390/diagnostics14040428.

2

F-Fluoride PET/CT Imaging of Medication-Related Osteonecrosis of the Jaw in Conservative Treatment-A Case Report.氟-18氟化物PET/CT成像在颌骨药物相关性骨坏死保守治疗中的应用——病例报告

Front Oncol. 2021 Jul 1;11:700397. doi: 10.3389/fonc.2021.700397. eCollection 2021.